α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes

Journal of Neuroscience

Volumn 17, Issue 14, 1997, Pages 5263-5270

  Michael McIntosh, J ^a  

^a 201 S Biology Building ^*  (United States)

Author keywords

Acetylcholine; Dopamine release; Hippocampus; Nicotine; Norepinephrine release; Striatum; conotoxin MII; 3 2 receptor

Indexed keywords

CHOLINERGIC RECEPTOR; CONOTOXIN; DOPAMINE;

ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; DOPAMINE RELEASE; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SYNAPTOSOME;

EID: 16944362902     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.17-14-05263.1997     Document Type: Article

References (19)

1. Cartier GE, Yoshikami D, Gray WR, Luo S, Olivera BM, McIntosh JM (1996a) A new α-conotoxin which targets α3β2 nicotinic acetylcholine receptors. J Biol Chem 271:7522-7528.
2. Cartier GE, Yoshikami D, Luo S, Olivera BM, McIntosh JM (1996b) α-Conotoxin MII (α-Ctx-M II) interaction with neuronal nicotinic acetylcholine receptors. Soc Neurosci Abstr 22:268.
3. 3H]-dopamine release. Br J Pharmacol 111:695-702.
4. Conroy WG, Berg DK (1995) Neurons can maintain multiple classes of nicotinic acetylcholine receptors distinguished by different subunit compositions. J Biol Chem 270:4424-4431.
5. Di Chiara G (1995) The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 38:95-137.
6. El-Bizri H, Clarke PBS (1994) Blockade of nicotine receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br J Pharmacol 111:406-413.
7. Fiordalisi JJ, Al-Rabiee R, Chiappinelli VA, Grant GA (1994) Affinity of native κ-bungarotoxin and site-directed mutants for the muscle nicotinic acetylcholine receptor. Biochemistry 33:12962-12967.
8. Freedman R, Adler LE, Bickford P, Byerley W, Coon H, Cullum CM, Griffith JM, Harris JG, Leonard S, Miller C, Myles-Worsley M, Nagamoto HT, Rose G, Waldo M (1994) Schizophrenia and nicotinic receptors. Harvard Rev Psychiatry 2:179-192.
9. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587-592.
10. 3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856.
11. Grandinetii A, Morens DM, Reed D, MacEachem D (1994) Prospectivestudy of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 139:1129-1138.
12. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383:713-716.
13. Groebe DR, Dumm JM, Levitan ES, Abramson SN (1995) α-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors. Mol Pharmacol 48:105-111.
14. Harvey SC, McIntosh JM, Cartier GE, Maddox FN, Luetje CW (1997) Determinants of specificity for α-conotoxin Mil on α3β2 neuronal nicotinic receptors. Mol Pharmacol 51:336-342.
15. Janson AM, Fuxe K, Sundstrom E, Agnati LF, Golstgein M (1988) Chronic nicotine treatment partly protects against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of nigrostriatal dopamine neurons in the black mouse. Acta Physiol Scand 132:589-591.
16. Johnson DS, Martinez J, Elgoyhen AB, Heinemann SS, McIntosh JM (1995) α-Conotoxin ImI exhibits subtype-specific nicotinic acetylcholine receptor blockade: preferential inhibition of homomeric α7 and α9 receptors. Mol Pharmacol 48:194-199.
17. Koob G (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184.
18. Kreienkamp H-J, Sine SM, Maeda RK, Taylor P (1994) Glycosylation sites selectively interface with α-toxin binding to the nicotinic acetylcholine receptor. J Biol Chem 269:8108-8114.
19. 3H]methylcarbamycholine binding sites in rat brain. J Neurochem 52:483-491.